Showing 1801-1810 of 8891 results for "".
Drug-Induced Dermatomyositis
https://practicaldermatology.com/topics/atopic-dermatitis/drug-induced-dermatomyositis/23357/It’s common practice to screen for underlying malignancy in dermatomyositis, but it is also important to look for drug-induced disease.Systemic Inflammation in Psoriasis: A Guide for Dermatology Care Providers
https://practicaldermatology.com/topics/psoriasis/systemic-inflammation-in-psoriasis-a-guide-for-dermatology-care-providers/20439/Practical guidance for dermatology care providers on the importance of screening patients with psoriasis for associated comorbidities.Mind the Gap (Year): Being Mindful of Dedicating a Year to Research During Medical School
https://practicaldermatology.com/topics/practice-management/mind-the-gap-year-being-mindful-of-dedicating-a-year-to-research-during-medical-school/23783/A research year can have benefits, but it may not give residency applicants the edge they expect.Dermal Micro-Coring 101
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dermal-micro-coring-101/23376/Expert insight on a new energy-free facelift alternative.Dispatches from the 2022 Skin of Color Update
https://practicaldermatology.com/conferences/skin-of-color-update-2022/dispatches-from-the-2022-skin-of-color-update/23822/Co-chair Dr. Andrew F. Alexis shares highlights from the recent meeting.A Definitive Guide to Recognizing and Treating “Maskne”
https://practicaldermatology.com/columns/clinical-focus-1/a-definitive-guide-to-recognizing-and-treating-maskne/23520/Practical Dermatology® magazine’s resident acne columnist offers step-by-step guidance.Out With the Old, In With the New
https://practicaldermatology.com/topics/psoriasis/out-with-the-old-in-with-the-new-1/23430/A “new” way of assessing psoriasis severity may improve access to care.Core Marketing Philosophies and Your Practice
https://practicaldermatology.com/topics/practice-management/core-marketing-philosophies-and-your-practice/21032/The most successful practices treat formulas and strategies as loose parameters rather than hard-set rules to adhere to.The Future of Interleukin-based Therapy
https://practicaldermatology.com/topics/practice-management/the-future-of-interleukin-based-therapy/21133/IL inhibitors offer the promise of increased efficacy. Here is a snapshot view of current and investigational agents.How To Overcome “LCD” Planning in a Group Practice
https://practicaldermatology.com/topics/practice-management/how-to-overcome-lcd-planning-in-a-group-practice/21182/Concepts to be implemented to help you avoid LCD planning and address significant financial threats.